FDA Surveillance of Financial Conflict Of Interest Needs To Increase - Henney
Executive Summary
Increased surveillance of financial conflict of interest is needed to guard against even a perception of bias by the public, FDA Commissioner Henney indicated during HHS' meeting on human subject protection and financial conflict of interest Aug. 15 at NIH.